Loading chat...

DE HB21

Bill

Status

Passed

7/21/2025

Primary Sponsor

Kimberly Williams

Click for details

Origin

House of Representatives

153rd General Assembly

AI Summary

  • Classifies tianeptine as a Schedule I controlled substance in Delaware, including all its salts, isomers, and preparations containing any quantity of the drug

  • Prohibits the manufacturing, selling, or delivery of tianeptine, with violations subject to existing controlled substance penalties under Chapter 47

  • Creates an exception that prevents civil or criminal penalties from being imposed for simple possession of tianeptine by individuals

  • Protects individuals from criminal or civil asset forfeiture for tianeptine possession

Legislative Description

An Act To Amend Title 16 Of The Delaware Code Relating To Tianeptine.

Last Action

Signed by Governor

7/21/2025

Committee Referrals

Health & Social Services3/20/2025
Health & Human Development12/19/2024

Full Bill Text

No bill text available